KIAA1033 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.901200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.525600E-01
Normal-vs-Stage2
2.958600E-01
Normal-vs-Stage3
1.892360E-01
Normal-vs-Stage4
2.048800E-01
Stage1-vs-Stage2
8.235000E-01
Stage1-vs-Stage3
1.358160E-01
Stage1-vs-Stage4
9.225200E-01
Stage2-vs-Stage3
5.397500E-04
Stage2-vs-Stage4
7.614800E-01
Stage3-vs-Stage4
3.251600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.902800E-01
Normal-vs-AfricanAmerican
2.900000E-01
Normal-vs-Asian
2.114200E-01
Caucasian-vs-AfricanAmerican
2.245200E-01
Caucasian-vs-Asian
8.415800E-02
AfricanAmerican-vs-Asian
5.378500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.959600E-01
Normal-vs-Female
2.860600E-01
Male-vs-Female
7.365800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.484400E-01
Normal-vs-Age(41-60Yrs)
3.601200E-01
Normal-vs-Age(61-80Yrs)
2.646800E-01
Normal-vs-Age(81-100Yrs)
4.079700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.445000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.580400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.111600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.922400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.164200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.612200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.519400E-01
Normal-vs-Daily Drinker
2.283800E-01
Normal-vs-Weekly Drinker
2.394000E-01
Normal-vs-Occasional Drinker
4.579600E-02
Normal-vs-Social Drinker
5.518000E-02
Non Drinker-vs-Daily Drinker
4.817600E-01
Non Drinker-vs-Weekly Drinker
7.086000E-01
Non Drinker-vs-Occasional Drinker
2.731400E-01
Non Drinker-vs-Social Drinker
2.227600E-01
Daily Drinker-vs-Weekly Drinker
8.260600E-01
Daily Drinker-vs-Occasional Drinker
1.371000E-01
Daily Drinker-vs-Social Drinker
1.113240E-01
Weekly Drinker-vs-Occasional Drinker
2.680400E-01
Weekly Drinker-vs-Social Drinker
2.234600E-01
Occasional Drinker-vs-Social Drinker
9.133200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.654440E-01
Normal-vs-Grade 2
4.661900E-02
Normal-vs-Grade 3
3.902000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.973400E-01
Grade 1-vs-Grade 3
2.209600E-01
Grade 1-vs-Grade 4
1.654440E-01
Grade 2-vs-Grade 3
1.734840E-01
Grade 2-vs-Grade 4
4.661900E-02
Grade 3-vs-Grade 4
3.902000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.599000E-01
Normal-vs-NonDiabetic
2.651200E-01
Diabetic-vs-NonDiabetic
8.151600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.038000E-01
Normal-vs-NoPancreatitis
2.730400E-01
Pancreatitis-vs-NoPancreatitis
7.101900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.063850E-02
Normal-vs-N1
2.963800E-01
N0-vs-N1
6.692200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.781400E-01
Normal-vs-TP53-NonMutant
2.983000E-01
TP53-Mutant-vs-TP53-NonMutant
6.486200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
